About the Book

This is about the future of life on Earth

Genomics is no longer just a science—it is becoming a widely adopted tool, like AI or mobile phones.

Because a technology that can change lineages forever deserves at least the scrutiny AI gets for merely changing economies — and right now it is getting a fraction of the attention.

We can now read DNA at mass scale and edit individual DNA bases, genes and genetic pathways with a speed, precision and scalability that would have been unthinkable a generation ago. CRISPR changed genome editing from a specialist, difficult tool into something many labs can now use routinely, including in large-scale screens involving thousands of edits. We can now store, sell and redesign living systems on an industrial scale. That means our bodies; our children and their children; our food; our diseases; our ecosystems; the species we may save, the species we may lose, and the species we may one day decide to create.

That should make all of us pay attention. Airplanes and mobile phones changed our lives profoundly—reshaping our cities, our daily routines and even the biosphere in ways their inventors could never fully foresee. The air industry brought us exciting new jobs like pilot and air steward. Airplanes meant people from different continents could meet and fall in love. Mobile phones meant they could always stay connected with their loved ones. We got mobile apps which changed the way we work and relax. We are now in the age of AI, where large language models are changing how we communicate and live, bringing significant benefits as well as consequences that range from demand for rare-earth minerals to effects on mental health.

The transformation of society through genomics may be more profound still, bringing both the opportunity and the risk of changing not only humanity, but every living thing on Earth, forever.

The Genomic Power Shift is a book about what happens when DNA stops being something only nature writes—and becomes something humans can read, copy, search, modify and build with. Our bodies, animals, plants and entire ecosystems are beginning to look like modelling materials—something we can reshape and build anything we want with – it is an exhilarating thought, and at the same time terrifying.

The public conversation is too small

The strange thing is how quietly this is happening. Artificial intelligence, robots and crypto get endless attention. Genomics may be orders of magnitude more transformative than AI because it can reshape living systems, inheritance, reproduction, ecosystems and the biosphere itself. Yet most people still lack even the basic language needed to understand what is coming.

That matters, because genomics is not only another technology sector. AI can change economies. Genomics can change lineages forever. When genetic changes are heritable, released into ecosystems, or scaled through populations, they can be extremely difficult—and sometimes impossible—to reverse.

With genomics we can alter embryos, species, crops, pathogens and ecosystems. It can help cure disease, but also deepen inequality. It can protect biodiversity, but also disrupt nature. It can reveal family secrets, identify strangers from DNA, reshape policing, transform fertility, and change what future generations inherit.

Some of these changes will be life-saving. Others may be life-threatening, with effects as serious as a pandemic outbreak. Because genomics and technologies such as gene editing can affect humanity and the living world so profoundly, we need to treat them with the seriousness they deserve. The lives of future generations—and life on Earth—may depend on it.

What the author has seen

Dr. Magdalena Zarowiecki has seen developments that once seemed miraculous or like science fiction. Cancer has moved from being described mainly by where it appears in the body to being understood increasingly through mutations, methylation, expression, resistance and molecular pathways. Precision-medicine approaches now save lives every day.

She has seen families affected by rare disease move from years of uncertainty towards answers—“we know precisely why you are ill”—and, in some cases, towards therapies that would once have sounded impossible.

She has seen clinical genomics become infrastructure: pipelines, reports, tumour boards, patient data, diagnostics, trial matching and real decisions made under time pressure.

She has seen biodiversity collapse accelerate at the same moment genomics is giving us new tools to understand, monitor and perhaps protect the living world.

She has seen antimicrobial resistance rise as one of the great biological threats of our time, reshaping risks for populations around the world.

And she has seen investors, startups, public health systems, researchers and governments all rush toward biology as the next great technology platform—often faster than society can think through the longterm consequences. Genomics is now becoming a multibillion-dollar industry, attracting investors from many sectors, some with a limited understanding of biological complexity and its associated risks.

What this project is for

The Genomic Power Shift is for people who want to understand what genomics has to do with them. Not in fifty years, but now—and in the transformative five to ten years ahead.

Your genome is already medically useful. Your child’s genome may be sequenced. Your cancer treatment may depend on molecular profiling. Your relatives may be found through DNA databases. Your food may be genetically edited. Your data may become part of a research system. Your planet is losing species at catastrophic speed while we read the genomes of the species that remain and consider genetically engineering ecosystems for greater climate resilience.

This book explains the science clearly, but it is not only a science book. It is about power.How will your life change because of it?
Which people will be winners and losers in the genomic paradigm?
Who gets treated and who gets left out?
Who owns the data?
Who protects the biosphere?
Is it possible to hold someone accountable for polluting the environment with synthetic DNA?
Who decides what kind of children, crops, animals, pathogens and ecosystems future generations inherit?

The aim

The aim is not to make genomics frightening, although even current technology could, if misused, contribute to mass-extinction events.

The aim is to make the technology understandable and approachable, and to involve the people affected in the decision-making process.

Genomics can do extraordinary good. It can help diagnose children, guide cancer treatment, track infections, find drug targets, protect endangered species and reveal the history of life itself.

AI, with all its promises and perils, is already the subject of robust public debate among researchers, companies, investors, governments and influential public voices. The same needs to happen with genomics, because the future of life on Earth depends on it.